PartⅡ Key to the Tasks
Task 10.1
Across
2.trans-
6.hydro-
7.onco-
10.nanoscience
11.liposome
12.poly-
Down
1.dendr-
3.re-
4.nano-
5.philic
8.oncology
9.-less
Task 10.2（No key)
Task 10.3
1.seamless transition；preclinical research；human applications
2.stabile；biodistribution；pharmacokinetic behavior；immunogenicity
3.genetic differences
4.the health of animals and the environment
5.early warning signs；susceptibility
Task 10.4
Task 10.5
1.D 2.C 3.C 4.A 5.B 6.C 7.B
Task 10.6（No key)
Task 10.7
1.biopharmaceutical research and development
2.socialize and use technology
3.detect your blood cholesterol
4.sensors and chips built into them
5.across all disease areas
6.tailored to the type of mutation
7.a metabolism analysis and a protein analysis
8.repair and replace lost or damaged tissue
9.the cells seeded from the patient
10.a very small orphan disease
11.targeted to the right tissue
12.an implantable pump
13.at molecular and cellular levels
14.increase to over$500 billion and$363 billion
15.innovative medicines becoming more accessible to patients
16.innovative medicines being delivered to patients
Task 10.8(https://www.daowen.com)
1.biomedical
2.translational
3.shift
4.nanotechnology
5.individualized
6.contemporary
7.address
8.academia
9.preclinical
10.applications
11.seamless
12.bedside
13.experimental
14.unmet
15.cost
16.close
17.particle
18.hydrophilic
19.hydrophobic
20.modification
21.multifunctional
22.requirements
23.genomic
24.diagnostic
25.bioinformatic
26.targeted
27.therapy
28.regenerative
29.zoonotic
30.reemergence
31.setbacks
32.anomaly
33.open-heart
34.ventricle
35.adulthood
36.long-term
37.challenge
38.mutations
39.wheelchair
40.release
41.cells
42.electrocardiogram/ECG
43.life-threatening
44.gene-therapy
45.failure